HCHC - HC2 Holdings, Inc.

NYSE - NYSE Delayed Price. Currency in USD
5.82
-0.06 (-1.02%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close5.88
Open5.94
Bid5.30 x 2900
Ask6.45 x 800
Day's Range5.81 - 5.99
52 Week Range4.30 - 7.79
Volume279,930
Avg. Volume267,025
Market Cap259.365M
Beta1.89
PE Ratio (TTM)N/A
EPS (TTM)-1.62
Earnings DateAug 7, 2018 - Aug 13, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2013-08-28
1y Target Est13.50
Trade prices are not sourced from all markets
  • GlobeNewswire10 days ago

    HC2 Completes Sale of Pansend Life Sciences Portfolio Company BeneVir Biopharm to Janssen Biotech, Inc. for Up to $1.04 Billion

    In conjunction with the closing of the transaction, Janssen made an upfront cash payment of $140 million, of which HC2 received approximately $73 million. Before its sale to Janssen, BeneVir was a portfolio company within HC2’s Pansend Life Sciences (“Pansend”) subsidiary, led by David A. Present M.D., Founder and General Partner, and Cherine Eldumiati Plumaker, Founder and General Partner.

  • GlobeNewswirelast month

    HC2 Holdings to Participate at the 19th Annual B. Riley FBR Investor Conference

    HC2 Holdings, Inc. (“HC2” or “the Company”) (HCHC), a diversified holding company, announced today that it will be participating at the 19th Annual B. Riley FBR Investor Conference in Santa Monica, CA, on Thursday, May 24, 2018 at 11:30 a.m. PT (2:30 p.m. ET). HC2’s executive management team including Philip A. Falcone, Chairman, Chief Executive Officer and President, Michael J. Sena, Chief Financial Officer and Andrew G. Backman, Managing Director of Investor Relations and Public Relations will be participating at the conference.

  • Falcone Says Benevir Transaction Indicative of Portfolio's Value
    Bloomberglast month

    Falcone Says Benevir Transaction Indicative of Portfolio's Value

    Phil Falcone, HC2 Holdings Inc. chairman and chief executive officer, discusses the company's investments in biotech, broadcast and Vietnam with Bloomberg's Betty Liu on "What'd You Miss?" (Source: ...

  • Thomson Reuters StreetEventslast month

    Edited Transcript of HCHC earnings conference call or presentation 10-May-18 9:00pm GMT

    Q1 2018 HC2 Holdings Inc Earnings Call

  • Associated Presslast month

    HC2 Holdings: 1Q Earnings Snapshot

    The New York-based company said it had a loss of 81 cents per share. The diversified holding company posted revenue of $453.7 million in the period. HC2 Holdings shares have climbed roughly 7 percent since ...

  • GlobeNewswirelast month

    HC2 Holdings Reports First Quarter 2018 Results

    NEW YORK, May 10, 2018-- HC2 Holdings, Inc., a diversified holding company, announced today its consolidated results for the first quarter 2018, which ended on March 31, 2018.. “During the first quarter, ...

  • Md. biotech to be acquired by New Jersey pharmaceutical goliath
    American City Business Journalslast month

    Md. biotech to be acquired by New Jersey pharmaceutical goliath

    The final price, a bit more than a billion dollars, includes upfront cash and payments based on achieving certain milestones.

  • GlobeNewswire2 months ago

    HC2 Holdings Announces Pricing of Private Offering of $110 Million Senior Secured Notes to Refinance Senior Secured Bridge Loans

    HC2 Holdings, Inc. (“HC2”) (HCHC), a diversified holding company, announced today the pricing of $110 million aggregate principal amount of 11.000% Senior Secured Notes due 2019 (the “Notes”), representing an upsize from a previously announced proposed offering of $105 million aggregate principal amount. The Company expects to use the net proceeds from the issuance of the Notes to refinance all of its outstanding senior secured bridge loans (the “Bridge Loans”), for working capital for the Company and its subsidiaries and for general corporate purposes, including the financing of future acquisitions and investments. The net proceeds from the Bridge Loans were used by HC2 to complete various acquisitions, including the majority equity interest in DTV America Corporation, the assets of Mako Communications, LLC and Three Angels Broadcasting Network, Inc., as well as certain assets from OTA Broadcasting, LLC, Azteca America, and the acquisition of substantially all of the assets of Northstar and to pay fees and expenses relating to these acquisitions.

  • Moody's2 months ago

    HC2 Holdings, Inc. -- Moody's Says Sale of BeneVir Biopharm and tack-on note issuance are credit positive for HC2; no ratings impact

    Moody's Investors Service ("Moody's") commented on HC2 Holdings, Inc's. announcement that its Pansend Life Sciences subsidiary has agreed to sell BeneVir Biopharm, Inc. to Janssen Biotech, Inc. for an upfront cash payment of $140 million plus additional contingent payments of up to $900 million based on the achievement of certain predetermined milestones. For any credit ratings referenced in this publication, please see the ratings tab on the issuer/entity page on www.moodys.com for the most updated credit rating action information and rating history.

  • GlobeNewswire2 months ago

    HC2 Holdings Announces Launch of Private Offering of $105 Million Senior Secured Notes

    HC2 Holdings, Inc. (“HC2”) (HCHC), a diversified holding company, announced today a private offering of $105 million aggregate principal amount of its 11.000% Senior Secured Notes due 2019 (the “Notes”). The Company expects to use the net proceeds from the issuance of the notes to refinance all of its outstanding senior secured bridge loans (the “Bridge Loans”), for working capital for the Company and its subsidiaries and for general corporate purposes, including the financing of future acquisitions and investments. The net proceeds from the Bridge Loans were used by HC2 to complete various acquisitions, including the majority equity interest in DTV America Corporation, the assets of Mako Communications, LLC and Three Angels Broadcasting Network, Inc., as well as certain entities from OTA Broadcasting, LLC, Azteca America, and the acquisition of substantially all of the assets of Northstar and to pay fees and expenses relating to these acquisitions.

  • Janssen Biotech's proposed purchase of a Maryland biopharm firm could top $1B
    American City Business Journals2 months ago

    Janssen Biotech's proposed purchase of a Maryland biopharm firm could top $1B

    The Johnson & Johnson subsidiary declined to disclose the purchase price. The company being acquired provided the details.

  • Why HC2 Holdings Stock Is Surging Today
    Motley Fool2 months ago

    Why HC2 Holdings Stock Is Surging Today

    The company has struck a deal to sell a portfolio company for as much as $1 billion.

  • MarketWatch2 months ago

    HC2's stock rockets to pace premarket gainers after subsidiary holding's buyout deal

    Shares of HC2 Holdings Inc. rocketed 51% to pace all premarket gainers early Wednesday, putting them on track to open at a 2 1/2-year high, after the holding company said BeneVir Biopharm, a biopharmaceutical portfolio company within HC2's subsidiary Pansend Life Sciences, agreed to be acquired by privately held Janssen Biotech Inc. in a deal that could be valued at over $1 billion. "Our goal at BeneVir has been to develop T-Stealth, an oncolytic immunotherapy platform, to help patients whose tumors do not respond to current therapeutic options including immune checkpoint inhibitors," said BeneVir Chief Executive Matt Mulvey.

  • GlobeNewswire2 months ago

    HC2 Announces Pansend Life Sciences Portfolio Company BeneVir Biopharm to be Acquired by Janssen Biotech, Inc. for up to $1.04 Billion

    HC2 Holdings, Inc. (“HC2”) (HCHC), a diversified holding company, announced today that BeneVir Biopharm, Inc. (“BeneVir”), a privately-held biotechnology company developing oncolytic immunotherapies for the treatment of cancer, has entered into a definitive agreement to be acquired by Janssen Biotech, Inc. (“Janssen”). BeneVir is a portfolio company within HC2’s Pansend Life Sciences (“Pansend”) subsidiary.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of HCHC earnings conference call or presentation 14-Mar-18 9:00pm GMT

    Q4 2017 HC2 Holdings Inc Earnings Call

  • GlobeNewswire2 months ago

    HC2 Holdings Sets First Quarter 2018 Earnings Release Date and Webcast

    NEW YORK, April 24, 2018-- HC2 Holdings, Inc., a diversified holding company, announced today that it will release its financial results for the first quarter 2018 on Thursday, May 10, 2018 after the market ...

  • PR Newswire2 months ago

    Entravision Communications Corporation Announces Affiliation Partnership for KMCC-TV Las Vegas with Azteca America

    SANTA MONICA, Calif. , April 23, 2018 /PRNewswire/ --  Entravision Communications Corporation (NYSE: EVC), a diversified media company serving Latino audiences and communities, announced today an affiliation ...

  • Does HC2 Holdings Inc’s (NYSE:HCHC) Latest Financial Perfomance Look Strong?
    Simply Wall St.2 months ago

    Does HC2 Holdings Inc’s (NYSE:HCHC) Latest Financial Perfomance Look Strong?

    After reading HC2 Holdings Inc’s (NYSE:HCHC) latest earnings update (31 December 2017), I found it beneficial to look back at how the company has performed in the past and compareRead More...

  • Associated Press3 months ago

    HC2 Holdings reports 4Q loss

    On a per-share basis, the New York-based company said it had a loss of 21 cents. Losses, adjusted for costs related to mergers and acquisitions, came to 13 cents per share. The diversified holding company ...

  • ACCESSWIRE3 months ago

    HC2 Holdings, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / March 14, 2018 / HC2 Holdings, Inc. (NYSE: HCHC ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 14, 2018, at 5:00 PM Eastern Time. ...

  • Is HC2 Holdings Inc (NYSE:HCHC) A Financially Sound Company?
    Simply Wall St.5 months ago

    Is HC2 Holdings Inc (NYSE:HCHC) A Financially Sound Company?

    Investors are always looking for growth in small-cap stocks like HC2 Holdings Inc (NYSE:HCHC), with a market cap of $256.61M. However, an important fact which most ignore is: how financiallyRead More...

  • Should You Be Concerned About HC2 Holdings Inc’s (NYSE:HCHC) Investors?
    Simply Wall St.5 months ago

    Should You Be Concerned About HC2 Holdings Inc’s (NYSE:HCHC) Investors?

    In this article, I’m going to take a look at HC2 Holdings Inc’s (NYSE:HCHC) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject amongRead More...